Busulfan in patients with polycythemia vera or essential thrombocythemia refractory or intolerant to hydroxyurea A Alvarez-Larrán, L Martínez-Avilés, JC Hernández-Boluda, ... Annals of hematology 93, 2037-2043, 2014 | 91 | 2014 |
Infection and thrombosis associated with COVID-19: Possible role of the ABO blood group SZ Marcos, ML Antelo, A Galbete, M Etayo, E Ongay, JA García-Erce Medicina Clínica (English Edition) 155 (8), 340-343, 2020 | 51 | 2020 |
Circulating tumor cells in patients undergoing resection of colorectal cancer liver metastases. Clinical utility for long-term outcome: a prospective trial V Arrazubi, E Mata, ML Antelo, A Tarifa, J Herrera, C Zazpe, L Teijeira, ... Annals of surgical oncology 26, 2805-2811, 2019 | 33 | 2019 |
Clinical evaluation of the European LeukemiaNet response criteria in patients with essential thrombocythemia treated with anagrelide JC Hernández-Boluda, A Pereira, F Cervantes, M Gómez, ... Annals of hematology 92, 771-775, 2013 | 29 | 2013 |
Serial analysis of circulating tumor cells in metastatic breast cancer receiving first-line chemotherapy MJM Magbanua, LH Hendrix, T Hyslop, WT Barry, EP Winer, C Hudis, ... JNCI: Journal of the National Cancer Institute 113 (4), 443-452, 2021 | 26 | 2021 |
Optimised molecular genetic diagnostics of Fanconi anaemia by whole exome sequencing and functional studies M Bogliolo, R Pujol, M Aza-Carmona, N Muñoz-Subirana, ... Journal of medical genetics 57 (4), 258-268, 2020 | 25 | 2020 |
Incidence, diagnosis, and outcome of immune‐mediated thrombotic thrombocytopenic purpura: A nationwide survey by the Spanish registry of thrombotic thrombocytopenic purpura C Pascual‐Izquierdo, J del Rio‐Garma, J de la Rubia, A Viejo, E Mingot, ... Journal of Clinical Apheresis 36 (4), 563-573, 2021 | 18 | 2021 |
Mobilization of hematopoietic progenitor cells from allogeneic healthy donors using a new biosimilar G‐CSF (Zarzio®) ML Antelo, A Zabalza, MP Sánchez Antón, S Zalba, M Aznar, C Mansilla, ... Journal of Clinical Apheresis 31 (1), 48-52, 2016 | 18 | 2016 |
Improved traceability and transfusion safety with a new portable computerised system in a hospital with intermediate transfusion activity MJ Uríz, ML Antelo, S Zalba, N Ugalde, E Pena, A Corcoz Blood Transfusion 9 (2), 172, 2011 | 18 | 2011 |
Infección y trombosis asociada a la COVID-19: posible papel del grupo sanguíneo ABO SZ Marcos, ML Antelo, A Galbete, M Etayo, E Ongay, JA García-Erce Medicina clínica 155 (8), 340-343, 2020 | 15 | 2020 |
Evaluation of the post-transfusion platelet increment and safety of riboflavin-based pathogen reduction technology (PRT) treated platelet products stored in platelet additive … A Kaplan, B Lindgren, S Marschner, M Aznar, S Zalba, P Sánchez, ... Transfusion and Apheresis Science 54 (2), 248-252, 2016 | 12 | 2016 |
Clinico-biological characteristics of patients with myelofibrosis: an analysis of 1,000 cases from the Spanish Registry of Myelofibrosis I Pastor-Galán, JC Hernández-Boluda, JG Correa, A Alvarez-Larrán, ... Medicina Clínica (English Edition) 155 (4), 152-158, 2020 | 11 | 2020 |
Agreements and uncertainties in autologous haematopoietic stem cell mobilization and collection. A Spanish consensus document JL Bueno, A Alegre, O López-Villar, S Querol, JL Arroyo, R Goterris, ... Bone Marrow Transplantation 55 (4), 811-817, 2020 | 7 | 2020 |
Engraftment after autologous hematopoietic stem cell transplantation in patients mobilized with Plerixafor: A retrospective, multicenter study of a large series of patients ML Antelo, A Altuna, JJ Gimeno, JJ Ferreiro, C Amunárriz, JJ Mateos, ... Transfusion and Apheresis Science 60 (3), 103130, 2021 | 3 | 2021 |
Abstract A50: circulating tumor DNA (ctDNA) and magnetic resonance imaging (MRI) for monitoring and predicting response to neoadjuvant therapy (NAT) in high-risk early breast … MJM Magbanua, W Li, DM Wolf, C Yau, GL Hirst, L Brown-Swigart, ... Clinical Cancer Research 26 (11_Supplement), A50-A50, 2020 | 3 | 2020 |
Incidence, diagnosis, and outcome of acquired thrombotic thrombocytopenic purpura (aTTP): a nationwide survey by the Spanish apheresis group MCP Izquierdo, J del Rio-Garma, J De La Rubia, A Viejo, ... Blood 134, 4910, 2019 | 3 | 2019 |
Safety and efficacy of a G-CSF biosimilar (Zarzio (R)) for haematopoietic progenitor cell mobilization in allogeneic healthy donors ML Antelo, A Zabalza, MP Sanchez Anton, S Zalba, M Aznar, E Vicente, ... BONE MARROW TRANSPLANTATION 48, S102-S102, 2013 | 3 | 2013 |
Efecto de la aplicación del programa Patient blood management en el abordaje de las artroplastias de cadera y rodilla programada SZ Marcos, IP Martí, MLA Caamaño, JM de Morentin Garraza, ... Medicina clínica 155 (10), 425-433, 2020 | 2 | 2020 |
Abstract PD6-5: Pooled analysis of circulating tumor cells in metastatic breast cancer: Findings from 1944 individual patients data FC Bidard, D Peeters, T Fehm, F Nole, R Gisbert-Criado, D Mavrudis, ... Cancer Research 73 (24_Supplement), PD6-5-PD6-5, 2013 | 2 | 2013 |
Evolution of circulating tumor cells (CTCs) during neoadjuvant treatment and radical surgery in patients (pts) with liver-only metastases of colorectal cancer (L-CRC). L Teijeira, A Viúdez, V Arrazubi, J Verdun, MJ Uriz, ML Antelo, A Tarifa, ... Journal of Clinical Oncology 29 (15_suppl), e14146-e14146, 2011 | 2 | 2011 |